HarteHanks: IMA Celebrates HHS's Policy Shift on mRNA Vaccines Amid Health Concerns

### IMA Celebrates Policy Shift on mRNA Vaccines Amid Growing Health Concerns

The Independent Medical Alliance (IMA) achieves a significant policy victory as the U.S. Department of Health and Human Services (HHS) removes mRNA COVID-19 vaccines from the recommended immunization schedules for children and pregnant women. This pivotal decision comes in the wake of IMA's "Smart Moms Ask" campaign, which rallies tens of thousands of supporters within a mere ten days, culminating in a planned march at HHS's headquarters in Washington, D.C. The IMA's advocacy is deeply rooted in their "Four Pillars of Healthcare Reform," emphasizing the need for evidence-based medical practices that prioritize patient health over political or commercial interests.

Dr. Kat Lindley, Director of IMA's Fellowship Program, commends the HHS for its swift action, arguing that recent evidence fails to justify the continued inclusion of mRNA vaccines in pediatric vaccination schedules. A recent study published in the International Journal of Cardiovascular Research & Innovation raises serious concerns, revealing a staggering 620% increased risk of myocarditis and a 175% increased risk of pericarditis in young men following mRNA vaccination. This alarming data intensifies the IMA's call for a reassessment of the safety protocols surrounding these vaccines, particularly for vulnerable populations like children and pregnant women.

Dr. Joseph Varon, IMA President and Chief Medical Officer, asserts that the HHS's decision reflects an increasing awareness of the scientific community regarding the safety issues associated with mRNA vaccines. The organization continues to champion transparent, science-driven healthcare policies and aims to foster a broader reevaluation of mRNA vaccine safety in light of emerging evidence. As the IMA's leadership, including seasoned professionals like Dr. Lindley and Dr. Varon, resonates with a nationwide audience of concerned parents and healthcare professionals, their advocacy underscores the critical intersection of public health policy and community health concerns.

The IMA's efforts exemplify a growing movement among healthcare professionals advocating for patient safety and informed consent. With the HHS's recent decision, there is potential for a more rigorous examination of vaccination protocols, which could lead to significant changes in public health strategies. As the dialogue around vaccine safety continues to evolve, the IMA remains at the forefront, urging policymakers to prioritize scientific evidence over prevailing trends.

In addition to this policy victory, the IMA's ongoing initiatives seek to educate the public about the intricacies of vaccine safety and efficacy. Their commitment to transparency and evidence-based practices serves as a reminder of the vital role that healthcare advocacy plays in shaping public health outcomes. The organization stands prepared to engage in further discussions that prioritize the health and well-being of all individuals, particularly those who are most at risk.